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ABSTRACT 
Quinones are present in many drugs such as anthracyclines, 
daunorubicin, doxorubicin, mitomycin, mitoxantrones and 
saintopin, which are used clinically in the therapy of solid cancers. 
The cytotoxic effects of these quinone are mainly due to the 
inhibition of DNA topoisomerase-II. It is the necessity to develop 
the 1,4-Naphthoquinone analogues with Cytotoxic effect. Here 2-
[CH(OH)X]-5,8-(OY)2-1,4-Naphthoquinines analogues have been 
used to correlate the cytotoxic activity with the Eccentric 
Connectivity index (ECI), Fragment Complexity (FC) and McGowan 
Volumes (MG) for studying the Quantitative Structure Activity 
Relationship (QSAR). Correlation may be an adequate predictive 
model which can help to provide guidance in designing and 
subsequently yielding greatly specific compounds that may have 
reduced side effects and improved pharmacological activities. We 
have used Multiple Linear Regression (MLR), one of the best 
methods for developing the QSAR model. Results from this QSAR 
study have suggested that ECI, FC and MG are the important 
descriptors for cytotoxic activities of 1,4-Naphthoquinones against 
L1210 cells. For the validation of the developed QSAR model, 
statistical analysis such as data point-descriptor ratio, fraction of 
variance, cross validation test, standard deviation, quality factor, 
Fischer’s test; and internal validation such as Y-randomization test 
have been performed and all the tests validated this QSAR model. 
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INTRODUCTION 
Quinones of various chemical families 
serve as biological modulators and both 
synthetic and natural quinones are used as 
drugs (McIntire, 1998; Meganathan, 2001; Lee, 
1999; Begleiter, 2000). The well known 
members of the family are doxorubicin and 
daunorubicin, the first identified anthracyclines 
(Di Marco et al., 1981). Synthetic epirubicin and 
mitoxantrone are well known examples of 
other quinines as anti-cancer agents (Arcamone 
and  Cassinelli, 1998). 
Quinones also form a class of toxic 
metabolites generated by the metabolism of 
phenols, 1‐naphthol, and diethyl‐stilbesterol. 
The mechanisms by which quinones exert their 
toxic   effects  are  complex, but  two processes  
 
 
appear to be involved: the direct arylation of 
sulfhydryls, and the generation of active oxygen 
species via redox cycling. Certain quinones 
have been shown to be mutagenic via the  
active oxygen species and others via their 
conversion to DNA‐binding semiquinone free 
radicals. Paradoxically, quinones are not only 
mutagenic and therefore potentially 
carcinogenic; they are also effective anticancer 
agents. The design of novel quinones that are 
more selective in their toxicity to human             
tumor cells and whose mechanism of action             
is understood seems a promising approach                
in cancer treatment, especially if host                 
toxicity can be prevented via the use of           
chemo protective  agents  (Martyn  and  Smith, 
1985). 
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In the present study, we developed a 
Quantitative Structure Activity Relationship 
(QSAR) model on a series of 2-[CH(OH)X]-
5,8-(OY)2 -1,4-Naphthoquinones with respect 
to their cytotoxity against L1210 Cells. The 
QSAR studies are perfect tool for 
understanding the drug design process in terms 
of their chemical-pharmacological activity 
interaction, along with it is also used in 
toxicology and pesticide research. QSAR 
studies can focus on mechanism of action of 
ligands with human, bacteria, virus, 
membranes, enzymes etc. It can also be used 
for the evaluation of the metabolism, 
absorption, distribution and excretion 
phenomena. The QSAR methodology 
comprises of computationally derived 
descriptors to correlate with pharmacological 
activities. These descriptors are principally of 
four types such as electronic, stearic, 
hydrophobic and topological indices (Verma et 
al., 2010). The descriptors used by us for 
developing the QSAR model are Eccentric 
Connectivity Index (ECI) (Sardana and Madan, 
2003), Fragment complexity (FC) (Gregg, et al., 
2007) and McGowan’s volume (MG) (Michael 
et al., 2004). 
 
  
 
 
   
   
  
 
 
 
Figure 1. 2D structure of 2-[CH(OH)X]-5,8-(OY)2-1,4-Naphthoquinones pharmacophore for 
which the QSAR model has been developed and the derivatives 
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METHODOLOGY 
All the bioactivity values and 
information about 2D structure of 2-
[CH(OH)X]-5,8-(OY)2 -1,4-Naphthoquinones 
derivatives were taken from literature 
(Rajeshwar and Verma, 2006). IC50 is referred 
as the molar concentration of a compound that 
inhibits 50% growth of bacteria (Verma et al., 
2010; Chowdhury et al., 2012); log1/C is 
subsequent variable that comprises the 
bioactivity parameter for the QSAR model.          
In order to calculate the 2D molecular 
descriptors, PaDEL descriptor software           
(Yap, 2011) which incurporate CDK library          
for descriptor calculation have been used.            
For the development of QSAR model,   
Multiple Linear Regression has been employed 
(Verma et al., 2010). 
 
Statistical parameters 
In the QSAR model, number of data 
points is denoted as n, squared correlation 
coefficient as r2 (fraction of variance), cross-
validated r2 is denoted as q2, s is standard 
deviation, RMSD is root mean square 
deviation, variance. Q is quality factor, where 
Q= r/s (here r is correlation coefficient and s is 
standard deviation). Fischer statistics is denoted 
by F. 
Model validation 
The QSAR model validation was carried 
with statistical analysis and with internal 
validation. 
 
RESULT AND DISCUSSION 
The 2D structure of 2-[CH(OH)X]-5,8-
(OY)2-1,4-Naphthoquinones pharmacophore 
for which the QSAR model has been developed 
and the derivatives are shown in figure 1. From 
the data in table I, QSAR equation have been 
developed where number of data point (n) is 
10, is given below, here 95% confidence 
intervals are given in parentheses. 
log(1/C) = 11.103 ( ± 6.302) + 0.01 ( ± 
0.005) (ECI) - 0.001 ( ± 0.0024732) (FC) - 2.85 
( ± 3.976) (MG) 
 
Validation of QSAR model 
A quantitative assessment of model 
robustness has been performed through model 
validation. All the statistical results of model 
validation have been given in table II. 
Fraction of variance (r2) 
 The value of fraction of variance may 
vary between 0 (means model without 
explanatory power) and 1 (means perfect 
model). QSAR model having r2 > 0.6 will only 
be considered for validation (Verma et al., 2010; 
Sharma et al., 2009). The value for this QSAR 
model is 0.9293. 
 
Cross-validation test (q2) 
A QSAR model must have q2 > 0.5 for 
the predictive ability (Verma et al., 2010; Sahu et 
al., 2012). The value of q2 for this QSAR model 
is 0.9293. 
 
Standard deviation (s) 
The smaller s value is always required for 
the predictive QSAR model. The value of s for 
this QSAR model is 0.57. 
 
r2-q2 < 0.3 
The difference between r2 and q2 should 
never be exceed by 0.3. A large difference 
suggests the following: presence of outliers, 
over-fitted model, and presence of irrelevant 
variables in data (Verma et al., 2010). The value 
of r2-q2 for this QSAR model is 0. 
 
Quality factor (Q) 
Over fitting and chance correlation, due 
to excess number of descriptors, can be 
detected by Q value. Positive value for this 
QSAR model suggests its high predictive power 
and lack of overfitting (Verma et al., 2010). 
 
Fischer statistics (F) 
The F value of QSAR model was 
compared with their literature value at 95% 
level. The F value of this QSAR model is 
26.2885 (where F > Flit) suggests that the 
QSAR model is statistically significant at 95% 
level (Verma et al., 2010). 
 
Internal validation 
Y-Randomization test 
To establish the QSAR model 
robustness, this technique is being used          
widely. For this test, the dependent        
variable vector is randomly shuffled, and a         
new QSAR model is developed using the 
unchanged independent variable. This process 
was repeated for five times. The statistical          
data    of  r2   for  five runs are given in table III.  
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The values r2<0.6 in Y-randomization test 
confirm the robustness of this QSAR model 
(Verma et al., 2010). 
According to the developed QSAR 
model, the 2-[CH(OH)X]-5,8-(OY)2-1,4-
Naphthoquinones must have positive Eccentric 
Connectivity Index for enhanced cytotoxic 
action against L1210 cells at X and Y 
substituents. A negative coefficient of 
Fragment Complexity containing X and Y 
substituents also elevate the activity of 2-
[CH(OH)X]-5,8-(OY)2 -1,4-Naphthoquinones 
derivatives towards its cytotoxic action.  
Moving towards the effects of the McGowan 
Volume on the bioactivity of derivatives of 2-
[CH(OH)X]-5,8-(OY)2 -1,4-Naphthoquinones,  
the developed QSAR model suggest that a 
negative elevation in MG at substituent X and 
Y will definitely be favorable to the activity, as 
discussed by R. P. Verma and Corwin Hansch 
(Verma et al., 2010) in 2010, Ajeet et al., (2012) 
in 2012 and Ajeet (Ajeet, 2012) in 2012.                
A comparison (multiple linear regression plots) 
of observed values and predicted values                 
of log(1/C) for 2-[CH(OH)X]-5,8-(OY)2-             
1,4-Naphthoquinones   derivatives    used    for  
Table I. Descriptors used to derive QSAR equation along with bioactivities 2-[CH(OH)X]-5,8-
(OY)2 -1,4-Naphthoquinones analogues with substituents X , Y 
 
X Y 
log 1/IC ECI FC MG 
Obs. Pred. Resid. 
C4H9 CH3 6.52 6.226286 0.293714 371 1387.05 2.3222 
C12H25 H 6.1 6.131223 -0.03122 825 2965.05 3.1676 
C5H11 CH3 6.05 6.056366 -0.00637 426 1610.05 2.4631 
C7H15 CH3 5.54 5.768087 -0.22809 548 2104.05 2.7449 
C9H19 CH3 5.43 5.548557 -0.11856 686 2662.05 3.0267 
C12H25 CH3 5.37 5.275251 0.094749 916 3619.05 3.4494 
C4H9 H 6.85 7.076011 -0.22601 317 989.05 2.0404 
C5H11 H 7 6.923798 0.076202 369 1180.05 2.1813 
C7H15 H 6.7 6.650101 0.049899 483 1610.05 2.4631 
C9H19 H 6.52 6.42432 0.09568 611 2104.05 2.7449 
 
Table II. Results of statistical validation 
 
r2 q2 s r2- q2 < 0.3 Q F RMSD variance 
0.9293 0.9293 0.57 0 1.6912 26.2885 0.0480491 0.0384786 
 
Table III. Results of internal validation: Y-randomization test (5 runs) 
 
 Shuffled observed log 1/C 
Run 1 Run 2 Run 3 Run 4 Run 5 
1 5.43 6.1 6.85 5.54 7 
2 6.52 6.52 7 5.43 6.7 
3 7 7 6.7 5.37 6.52 
4 6.7 6.7 6.52 6.85 5.43 
5 6.52 6.52 6.52 7 5.37 
6 5.37 5.37 6.1 6.7 6.85 
7 6.85 6.85 6.05 6.52 6.52 
8 6.05 6.05 5.54 6.52 6.1 
9 5.54 5.54 5.43 6.1 6.05 
10 6.1 5.43 5.37 6.05 5.54 
r2 0.0757 0.2048 0.2944 0.1209 0.3758 
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development of QSAR equation is shown in 
Figure 2 and multiple linear graph is shown in 
Figure 3. 
 
CONCLUSION 
An analysis of developed QSAR model 
reflects a number of important points.           
Firstly it reveals that ECI, FC and MG are 
essential descriptors for the development of                 
2-[CH(OH)X]-5,8-(OY)2-1,4-Naphthoquinones 
derivatives. The developed QSAR model 
equation suggest that cytotoxic activity in terms 
of inhibition concentration might be improved 
by increasing the eccentric connectivity              
index by making modification at X, Y 
substituents of the 2-[CH(OH)X]-5,8-(OY)2-
1,4-Naphthoquinones pharmacophore along 
with ensuring that fragment complexity and 
McGowan Volume should be reduced 
simultaneously at the same X, Y substituents.  
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